Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling

Misha Nechay1, Danyang Wang1, Ralph E Kleiner1

  • 1Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.

Cell Chemical Biology
|July 11, 2023
PubMed

Insights

Oxaliplatin, a platinum drug for colorectal cancer, inhibits rRNA transcription by disrupting the nucleolus via ATM/ATR signaling. This distinct pathway silences transcription without direct DNA damage, revealing a key mechanism of platinum drug toxicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Platinum (Pt) compounds are crucial anti-cancer drugs.
  • The precise mechanisms of Pt drug action, particularly oxaliplatin, require further elucidation.
  • Understanding oxaliplatin's effects on rRNA transcription and nucleolar function is key to its therapeutic application.

Purpose of the Study:

  • To investigate the mechanism by which oxaliplatin inhibits rRNA transcription.
  • To determine the role of ATM and ATR signaling in oxaliplatin's effects.
  • To clarify the relationship between nucleolar disruption, DNA damage signaling, and transcriptional inhibition by oxaliplatin.

Main Methods:

  • Treatment of cells with oxaliplatin.
  • Analysis of rRNA transcription rates.
  • Assessment of ATM and ATR signaling pathway activation.
  • Investigation of nucleolar protein localization (NBS1, TOPBP1).
  • Evaluation of DNA damage markers in the nucleolus.

Main Results:

  • Oxaliplatin inhibits rRNA transcription through ATM and ATR signaling.
  • The drug causes nucleolar disruption and accumulation of NBS1 and TOPBP1.
  • Transcriptional inhibition is independent of NBS1 and TOPBP1.
  • Oxaliplatin does not induce significant direct DNA damage in the nucleolus.

Conclusions:

  • Oxaliplatin triggers a unique ATM/ATR signaling pathway that suppresses Pol I transcription.
  • This pathway operates independently of direct nucleolar DNA damage.
  • The study highlights a distinct mechanism of nucleolar stress and transcriptional silencing linked to DNA damage signaling, contributing to platinum drug cytotoxicity.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K